company-logo

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.

Ventyx Biosciences Dividend Announcement

Ventyx Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Ventyx Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Ventyx Biosciences Dividend History

Ventyx Biosciences Dividend Yield

Ventyx Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ventyx Biosciences stock? Use our calculator to estimate your expected dividend yield:

Ventyx Biosciences Financial Ratios

P/E ratio-1.39
PEG ratio0.04
P/B ratio0.76
ROE-54.94%
Payout ratio0.00%
Current ratio23.52
Quick ratio23.52
Cash Ratio5.02

Ventyx Biosciences Dividend FAQ

Does Ventyx Biosciences stock pay dividends?
Ventyx Biosciences does not currently pay dividends to its shareholders.
Has Ventyx Biosciences ever paid a dividend?
No, Ventyx Biosciences has no a history of paying dividends to its shareholders. Ventyx Biosciences is not known for its dividend payments.
Why doesn't Ventyx Biosciences pay dividends?
There are several potential reasons why Ventyx Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Ventyx Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Ventyx Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Ventyx Biosciences a dividend aristocrat?
Ventyx Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Ventyx Biosciences a dividend king?
Ventyx Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Ventyx Biosciences a dividend stock?
No, Ventyx Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Ventyx Biosciences stocks?
To buy Ventyx Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Ventyx Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.